The present invention generally relates to a two part IOL with a generally “L” or “S” shape but featuring two straight or rounded “V”-shaped structures. More specifically, the present invention relates to an IOL frame which is insertable through an opening as small as 1.0 mm or less by bending the arms of the “V”-shaped structures of the frame together or on top of each other, inserting a lens secondarily into the eye and attaching the lens onto the frame.
The history of intraocular lenses (IOLs) is a long and varied one. Intraocular lenses can be used to treat a wide diversity of eye conditions ranging from cataracts to any type of eyesight correction. In addition, IOLs can be used to replace an irreversibly damaged lens in the eye—aphakic eyes. Alternatively, the lenses can be used in addition to the natural lens to correct the vision—phakic eyes. These lenses can be placed in the anterior or posterior chambers of the eye.
Early IOL researchers were plagued with problems associated with the materials which were obtainable to them at the time (early 1950's) making the lenses too heavy and too large. Surgery of the eye was in its infancy and therefore there were many problems with the surgical procedures. Since that time the quality, size and weight of the optics as well as microsurgical procedures have dramatically improved.
The earliest IOLs were placed in the anterior chamber of the eye, this being the easiest chamber to get to. Along with the early problems with the optics and surgical techniques, placement of a lens in the anterior chamber proved difficult because the anterior chamber is narrow (about 1.5 to 2.5 mm).
The angle between the cornea and the iris was a location within the anterior chamber subsequently used for placement of IOLs. Angle supported anterior chamber IOLs took advantage of the anterior chamber angle to support and fix the IOL in place. By angling the IOL into opposite sides of the anterior chamber, the natural angle was used to keep the IOL from moving. However, early lenses experienced marked problems with endothelial loss due to chafing against the early thick lenses. Later lenses were able to reduce the significance of this problem, but still retained problems associated with placement of the IOL in the chamber angle. The biological properties of that angle make it a very sensitive area. The structures associated with equalizing the internal pressure of the eye are located in that area. Additionally, the tissue in the area is easily irritated and irritation initiates a growth of fibrous tissue, called synechiae. The IOL fixation must be gentle in order to reduce irritation, but stable enough that it will not be easily moveable. This compromise is difficult to obtain. In addition, although the results were excellent in the short-term, there was a significant problem in the long term with altered night vision, loss of endothelial cell populations and alteration of the anterior uvea. These problems, as well as the fact that such anteriorly positioned lenses were uncomfortable to the patient, caused many doctors to abandon anterior chamber IOLs.
A third location was developed later and involved implanting a contact lens between the iris and the natural lens. These lenses were called ICLs or implantable contact lenses. However, the ICLs were suspected of initiating cataracts and glaucoma.
As the development of the IOLs became more sophisticated, Ophthalmologists recognized various problems. A typical IOL is composed of an optic, the ‘lens’ part of the structure, and a mounting mechanism called a haptic. The haptics are the part of the IOL that comes in contact with the eye tissue to hold the lens optic in place. There were essentially two major types of haptics which were developed—fiber and plate haptics. Fiber haptics are slender strands of resilient material which are attached at one end to the optic, and which rest, at their other end, against the eye. Fiber haptics have the advantage of being very light and slender. This would seem to make them ideal by causing less damage to the tissue and additionally being aesthetically pleasing because they are very narrow. The slenderness makes it more difficult for someone looking at the patient to see the IOL through the eye. Plate haptics are machined or molded from stock materials and have a central optic and an outer perimeter which rests against the eye. Because of their size, plate haptics tend to be more easily seen from outside in the patient's eye and the addition of extra material weight to the IOL and reduced flexibility as compared to fiber haptics leads to poor fixation and consequent migration or dislocation of the IOL. While fiber haptics have the disadvantage of initiating a process in which the body builds fibrous tissue or synechiae around the fiber haptic which immobilizes the iris, the larger plate haptic very rarely, if ever, causes such a reaction.
The adverse problems associated with the earlier anterior chamber haptic designs encouraged the development of IOLs for the posterior chamber for the majority of implants.
The surgical process may or may not include removal of the diseased natural lens using a process called phakoemulsification. The more standardized procedure for lens implantation involves removal of a diseased natural lens followed by implantation of an artificial lens. Phakoemulsification of the diseased lens is accomplished through about a 2 to 4 mm (small) incision in the eye and through a capsulorhexis incision in the capsule that encloses the lens in the posterior chamber, then an artificial intraocular lens implant is implanted back through the capsulorhexus into the capsular bag. For other types of procedures, the natural lens may not require removal at all.
Related two-piece IOLs of the invention are incorporated herein by reference: U.S. Pat. Nos. 4,056,855; 4,911,715; 5,074,876; 5,769,889; 4,451,938; and U.S. patent application Ser. No. 09/631,576, filed Aug. 4, 2000.
As surgical procedures have developed, there is a trend toward reducing the size of the incision in the eye. Although a 3 mm incision does not usually require sutures for healing, it increases the chances of astigmatism or infection, heals slower, and may provide for a slower operation than if an incision of less than 3 mm is used. However, presently IOLs cannot be inserted into a very small incision, as small as about 1 mm.
Accordingly, an intraocular lens (IOL) has been developed. The intraocular lens features an optic and a haptic. The haptic is generally “L”- or “S”-shaped, but features straight or curved “V”-shaped structures which are relatively rigid, because they are fabricated from higher modulus (harder) materials, but, they are very narrow so they are flexibly springy when thin. This permits the arms of the haptic to be bent close to, or over each other to fit through a small incision. The mixture of the general “L”-shape with “V”-shaped elements of the haptic allows insertion of the haptic through an opening in the eye as small as about 1 mm. The haptic also features a fastening structure for the separate foldable optic, preferably a cleat. The foldable optic is inserted into the eye through the same ultra small incision and attached to the haptic, preferably the haptic cleat, by way of one or more formed apertures or eyelets on the optic. The arms which are typically made up of a frame lens support member and haptic support member can bend or flex together such that the frame can be manipulated through an incision less than about 2 mm and down to about 1 mm and potentially as narrow as about 0.5 mm with minimal contact with the tissues.
The narrow shape of the haptic arms of the preferred embodiment allows for very low forces when flexed, reducing perceptible sensitivity or irritating trauma. Disc shaped support feet on the frame are similar to older designs of plate lenses and minimize discomfort or synechiae.
The higher modulus springy polymeric material may be selected from polyimide, polyetheretherketone, polycarbonate, polymethylpentene, polymethyl methacrylate, polypropylene, polyvinylidene fluoride, polysulfone, polyphenylsulfone and polyether sulfone. Preferably, the higher modulus material is polymethylmethacrylate (PMMA). Preferably, the higher modulus material has a modulus of elasticity of about 100,000 to about 500,000 psi, even more preferably about 450,000 psi and has a Rockwell M scale hardness of 90 to 95.
In one embodiment, the haptic comprises a two point frame. The two point frame has two contact areas or zones which contact the tissue of the eye. In a further embodiment, the haptic comprises a three point frame. The three point frame has three contact areas or zones which contact the tissue of the eye. The frame forms three feet which may be fabricated from a single uniform piece of material. The haptic may contain a cleat for attachment of the lens.
In a further embodiment, the haptic comprises a four point frame. The frame forms four feet which may be fabricated from a single uniform piece of material. The haptic may contain a cleat for attachment of the lens.
In a further embodiment, the haptic comprises any iris clip pincher-type lens known to one of skill in the art, including but not limited to that known as a Worst iris clip (U.S. Pat. No. 5,192319, issued Mar. 9, 1993) or that identified in U.S. patent application Ser. No. 6,409,763, issued Jun. 25, 2002, both of which are herein incorporated by reference in their entirety. The clip may be envisioned to be situated anywhere on the haptic such that it can correctly contact the iris. Alternatively, the iris clip type lens can be produced to be a two part lens which is attachable using the eyelet and cleat attachment herein.
The optic may be any type of lens. Preferably, the optic is a refractive lens, or an interference lens, producing a thin optic. The optic could be toric, aspheric, multi-element, positive or negative.
FIGS. 8A-D are plan views of the method of making the haptic of the preferred embodiment.
FIGS. 9A-E are plan views of the haptic being inserted into an eye through an ultra-small incision. The arrows indicate which way the haptic is moved to allow insertion.
FIGS. 10A-C are plan views of the IOL of the preferred embodiment being surgically assembled in the eye.
FIGS. 12 A-H are plan views of the surgery which introduces the multi-part IOL of the preferred embodiment into the eye.
FIGS. 13A-C are plan views of the haptic of the preferred embodiment, showing the rounding of the haptics to produce more space for attachment of the eyelet to the cleat.
FIGS. 15A-C are plan views showing three embodiments of the haptic of the multi-part IOL in accordance with the preferred embodiment of the “S” shaped haptic.
FIGS. 17A-C are plan views of the haptic of
FIGS. 18A-E are plan views of the embodiment shown in
Accordingly, a haptic with a generally “L”, plural “L” or “S” shape but featuring one or more straight or curved (rounded) “V”-shaped structures has been developed for a two part IOL. This frame with narrow haptic structures is insertable through an opening in the eye as small as about 1 mm by a combination of manipulating the frame into the incision and flexing the arms of each “V”-shaped structure of the frame together or on top of each other. The IOL further comprises a lens which can then be implanted in the eye. This frame haptic is also lightweight, springy and non-irritating, low cost, surgically implantable with a minimum of trauma to the eye, aesthetically pleasing, and does not support fibrous tissue growth. This IOL works in the anterior or posterior chamber of the eye for phakic or aphakic lenses. This haptic additionally comprises a fastener for a separate optic.
This generally “L” or “S”-shaped IOL frame is a haptic system based on a high modulus, shaped skeletal frame or plate haptic. The more rigid material frame or haptic ensures that the lens and springy haptic assembly also exhibits high elastic memory, will maintain its shape, and will stay ideally situated in the anterior chamber angle of the eye or in the posterior chamber. In contrast, a haptic of a single soft material will not maintain a desirable shape and will be more noodle-like in its spirit and will not be stable in the eye. The springy skeletal frame segments of the preferred design are thicker axially than they are radially which will minimize vaulting (i.e. axial motion) due to normal movements of the eye. Additionally, the eyelet aperture is slightly larger than the cleat, allowing nominal frame flexure without effecting the optic.
The embodiment shown in
The ability to replace the lens makes the IOL advantageous for use in any patient who may experience refractive changes in the eye. For example, in children, when a lens is implanted, it may need to be changed every 2 years or more when the eye changes refraction. However, with the embodiments shown herein, the optic may easily be removed and replaced with the correct lens. This allows a continuous adjustment for perfect vision.
The IOL described herein may be inserted into the eye through a very small opening of less than 2.5 mm and as little as 1.0 mm or less. This is difficult to do, since many IOLs may experience damage when inserted into a small opening. In addition, this allows for quicker healing and recovery and reduces the chances of infection.
Insertion of the lens into the eye involves a technique which snakes or manipulates the haptic into the eye with or without flexure of the haptics. The optic may be inserted separately and the two pieces may then be assembled within the eye. Alternatively, the pieces may be partially or completely assembled outside of the eye and inserted together. For example, the haptic may be inserted up to the furthest cleat. The optic may then be partially assembled by attaching the eyelet of the optic onto the cleat of the haptic. The assembly may then be completed within the eye or as the partially assembled IOL is inserted. Alternatively, the optic may be placed within the eye and the haptic inserted after. Assembly may then take place within the eye. The need to insert a haptic after the optic may arise due to damage or miss-sizing of the original haptic. Once the original haptic is removed, the correctly sized or undamaged haptic may be inserted.
The surgery which involves implanting the IOL of the preferred embodiments into the eye is preferably as brief as possible to provide for the least discomfort to the patient, the fastest healing time (due to less trauma) and the least risk of infection. Thus, after the incision is made and the viscoelastic inserted, implanting the frame should take no more than about two minutes, preferably 1 minute, more preferably 45 seconds, 30 seconds or even more preferably no more than about 15 seconds.
After insertion of the lens into the eye, assembly of the first eyelet onto the frame should take no more than 2 minutes, preferably 1 minute, more preferably 45 seconds, 30 seconds or even more preferably no more than about 15 seconds. Similarly, the second cleat assembly should take no more than 2 minutes, preferably 1 minute, more preferably 45 seconds, 30 seconds or even more preferably no more than about 15 seconds. Any surgery and implant assembly in the living body that involves more complex designs including screws or threads or hinge mechanisms or even banding would probably exceed these times.
The intraocular lens may be used to correct any malfunction of the eye which involves the lens, including myopia of from −8 to −20 D, cataracts, phakic or aphakic eyes, hyperopea, prespyopia, or any requirement from about −20.0 D to about +30.0 D.
Dimensions for the haptics of the preferred embodiments may be varied so as to fit the patient's eyes. Typically, the haptic may be from about 11 to 15 mm to fit the anterior chamber, including 11.5 mm, 12 mm, 12.5 mm, 13 mm, 13.5 mm, 14 mm, and 14.5 mm as well as increments between these dimensions, preferably from about 12 to about 13.5 mm. Typically, the haptic may be from about 11 to 15 mm to fit the posterior chamber, including 11.5 mm, 12 mm, 12.5 mm, 13 mm, 13.5 mm, 14 mm, and 14.5 mm as well as increments between these dimensions, preferably from about 12.5 to about 13.0 mm.
Other traits which are advantageous for a posterior chamber haptic include the haptic frame angling or vaulting backward instead of forward. The vaulting allows for a safer fit within the eye, reduces the possibility of the lens touching the tissue of the eye and reduces the chances that the haptic feet will obstruct the eyelet/cleat attachment. The vault 180, as shown in
The haptics may be the same width and thickness or may vary within parameters. Typical widths and thicknesses for the haptics include from about 0.05 to about 0.50 mm, including about 0.05, 0.75, 0.9, 0.1, 0.12, 0.13, 0.14, 0.15, 0.16, 0.17, 01.8, 0.19, 0.2, 0.21, 0.22, 0.23, 0.24, 0.25, 0.26, 0.27, 0.28, 0.29, 0.30, 0.31, 0.32, 0.33, 0.35, 0.38, 0.40, 0.41, 0.42, 0.45, 0.47, 0.48, and 0.49 mm.
The cleat and eyelet attachment of the preferred embodiment provides for ease in attaching the lens to the haptic. There are two features of the haptic that cause the bowing out of the haptic, the vaulting, which is produced during machining of the haptic, and the preload, which enhances the vaulting. These features allow the haptic to provide for slight variations in the corneal angle and physiology and movement of the eye. In addition, the vaulting of the haptic allows the surgeon to more easily attach the lens to the haptic with little or no obstruction. For this reason, the axial spaces on the haptic may preferably be not less than the eyelet thicknesses (or the vault space). This is because, to attach the lens to the haptic, the surgeon may wish to slide the lens body with the eyelet over the frame, through the frame and then to retract the lens in reverse so the eyelet can pass along and under the frame and between the frame and the iris tissue. For the subsequent hooking there will be an additional step of stretching and/or compressing (flexing) the frame up to about 0.5 mm.
The embodiments of the multi-part IOLs will now be described with reference to the Figures and Examples.
Referring to
The more standardized procedure for the removal of a diseased natural lens 30 followed by implantation of an artificial lens involves the phakoemulsification of the diseased lens through a small incision in the eye and through a capsulorhexis incision in the capsule that encloses the lens in the posterior chamber 18, then an artificial intraocular lens implant is implanted back through the capsulorhexus into the capsular bag. For other types of procedures, the natural lens 30 may not require removal at all. The IOL 10 of the preferred embodiment includes a separate centrally located optical zone or lens 200 and may be configured for implantation into either the anterior 16 or posterior chamber 18 and may be used for either procedure set out above. The haptic 110 of the IOL 10 extends radially outwardly in the general plane of the optic 200.
With reference now to
With reference to
With further reference to
The lens optic 200 can be attached to the frame haptic 110 in a variety of ways. A preferred embodiment is shown in
With reference to
In one embodiment, shown in
Therefore it is envisioned that the cleats 300 could be used to attach any type of IOL before insertion or after insertion. In addition, the cleats 300 would allow the surgeon a choice of lens types or powers to insert and the surgeon could potentially clip one or more lenses 200 onto the cleat 300. The cleats 300 would also allow for the replacement of a lens 200 as necessary due to a change in the power or type of lens 200 needed. A further aid to the surgeon would be to tint the cleats 300 and/or eyelets 400 such that they would be more visually identifiable to the surgeon during the operation.
With reference to
The embodiment shown in
With reference to
The process of CNC milling and lathe cutting is now described: A round blank 400 from about 13 mm to 19 mm diameter is cored from a sheet of PMMA about 1 mm to 4 mm thick. The blank 400 is assembled onto a blocker 500 (see
The thin frame haptic 110 is typically next polished to remove any rough edges. The preferred method of polishing involves abrasive tumble agitation polishing with a media comprising glass beads and water with an abrasive.
In the preferred embodiment, the frame haptic 110 is polymethylmethacrylate which has a tensile modulus of about 450,000 psi (using test method D 638 of the ASTM). In the preferred embodiment the feet 121 are identical, but, non-identical feet 121 configurations can be paired for use in an alternative embodiment when necessary. The narrowness of the frame haptic segments 110 contributes to its springiness and lightness which is advantageous in that the IOL is less likely to be disrupted from its initial position, but still be able to automatically adjust to a non-round corneal/iris angle diameter without excessive forces. This allows for the fact that the cornea may be elliptical or oblong. The haptic 110 can be as narrow as about 0.05 mm to about 0.25 mm, preferably about 0.18 mm or between about 0.15 mm and about 0.22 mm.
The lenses of these designs are typically about half the weight of a standard lens and can be between 2 to 10 milligrams and as low as 1 milligram in weight in air and about 10% of this when in the aqueous of the eye. Preferably the lens is flexible but may be made of a hard, stiff, low memory material. However, in the preferred embodiment, the lens is made of silicone and the chosen silicone can be as low as 15 shore A. The index (N) value would be 1.430 to 1.460 or flexible acrylic N=1.45 to 1.47.
FIGS. 9A-E illustrate how the haptic frame can be manipulated through a very small incision by flexing of the arms of the “V”-shaped structures. In FIGS. 9A-E, the combination of the generally “L”-shaped haptic and bendable “V”-shaped structures allows for insertion through a very small incision 500 by flexing the arms of the “V” shaped structures of the haptic as it is manipulated and moved into the eye 1. In fact, in most embodiments, the arms of the “V” shaped structures are induced to bend by the living tissue of the incision as they are manipulated through the incision and are temporarily pushed together or over each other by the tissue of the eye. Alternatively a forceps or a push-rod configured probe can be used to aid in the bending of the “V”-shaped structures. It can be envisioned that the haptic can be manipulated into the eye 1 by holding onto the bottom of the “V”-shaped structure, between the arms, as it goes into the eye and the eye tissue itself will cause the arms of the “V” to flex up to or over themselves.
In FIGS. 9A-E, the haptic 110 is inserted into the very small opening 500 and positioned in the eye as desired. In
In most previous IOLs, the lenses or optics 200 have predominantly been round. However, it can be envisioned that the lens 200 in the preferred embodiment of the present IOL 10 can be of many shapes. For example, the lens 200 may be oval, which would advantageously make the IOL narrower. Alternatively, the lens 200 may be segmented or chopped at one side to reduce the overall width of the IOL 10. The optic 200 may also have a parallelogram shape or even a trapezoid shape again allowing for a reduction in overall width. In this case the IOL 10 may have up to four eyelets 400 or even up to six or eight for rotational adjustment.
An embodiment of the surgical technique is shown in FIGS. 12A-H. The incision is performed as in
In order to increase the ease of attachment of the optic 200 to the haptic 110, a further embodiment is shown in
An alternative embodiment of the IOL is shown in
Alternative embodiments, shown in
In
The last step of assembling the optic 200 onto the haptic 110 may be accomplished as it was in FIGS. 10A-C with an alternate embodiment. As with the alternate embodiment, it is to be understood that the optic 200 may be assembled onto the haptic 110 as it is being inserted into the eye 1. Alternatively, the optic 200 may be partially or completely assembled onto the haptic before it is inserted into the eye.
Preferred embodiments of the intraocular lens and the insertion of the intraocular lens will now be described in the Examples.
An embodiment of the haptic and optic was produced using PMMA haptics of a variety of sizes to fit any eye. Because the anterior chamber can be hard to fit correctly, due to its uneven nature, the haptic may require replacement with a slightly different sized haptic to correctly fit. Thus, 12.0, 12.5, 13, and 13.5 mm haptics were initially available. At each size, the haptics conform to the anterior chamber without compressing the 5.5 mm silicone optic. Initially, a haptic modeled on the embodiment shown in
A 1.5 mm incision is made near the limbus of the eye. Viscoelastics are then injected into the anterior chamber. The frame is inserted as shown in FIGS. 9A-E. Then the lens is inserted and attached as shown in FIGS. 10A-C: the surgeon grasps the folded optic with the outside (distal) eyelet leading forward (see
The intraocular lens was implanted into 6 patients in Spain in a Clinical Trial. All patients experienced an increase in best-corrected visual acuity of 1-2 Snellen lines. The results of 3 patients will be presented in more detail in Example 2.
An lens according to the present invention with the trademark Kelman Duet Implant™ was used. The eyes of three patients were implanted with the Kelman Duet Implant™ by Dr. Jorge L. Alio at the Instituto Oftalmologico De Alicante in Spain. The patients were followed for 3 to six months. A 10.5 D optic and a 12.5 mm frame were used as follows:
The surgery was performed as in FIGS. 12A-H (see also
Lasik was performed to solve the remaining astigmatism and residual myopia (as only 10.5 D IOLs were available) and to achieve good visual acuity with no correction. Patient 1 even with a −2 cylinder did not require Lasik or addition correction to achieve good vision. Glare was reported only when it was asked for the purpose of the questionnaire, otherwise the patients did not complain about glare.
Although the performance of Lasik secondary to a Phakic IOL implantation could lead to a risk of loss of visual acuity, it was not observed in the three cases. The lens position was checked at three months and remained in proper position; the lens was very stable due to its independent optic. The endothelial counts remained stable, thus, the IOL did not activate cellular multiplication.
Because patient 1 was implanted with a frame that was too large for that patient's eye, replacement of the frame was performed by leaving the optic inside of the anterior chamber and removing the haptic in a reverse of
In the tables: ACD=anterior chamber depth, IOP=intraocular pressure, UCVA=uncorrected visual acuity, BCVA=best corrected visual acuity, W-to-W=white to white. M1=the first month, M3=the third month, M6=the sixth month.
Therefore, the description and examples show that the IOL of the present invention presents a number of advantages. It is inserted in two separate pieces significantly reducing the bulk so that the incision can be as narrow as 1 mm. The narrow shape of the haptic arms allows for very low forces when flexed reducing perceptible sensitivity or irritating trauma which reduces corneal chafing and pupilary block. The disc shaped support feet on the frame are similar to older designed plate lenses and will minimize synechiae. Lastly, it can be used in a phakic or aphakic eye.
One advantage of the present invention is that because the lens is a multi-part assembly, the ideal properties of each part of the IOL can be retained. For example, the haptic is ideally more rigidly springy with high memory and can be constructed to fit into a very narrow incision. In addition, Since the haptic is not rigidly connected to the optic and the connections themselves allow for some movement, the entire length of the haptic is available for flexure. This can be envisioned as being comparable to the flexibility in a long, flat, thin piece of steel. It has some flexibility if sufficiently thin. However, if the same piece of steel is only 2 inches long, it is considerably less flexible. The lens, although it is between 3 mm and 7 mm, including about 4 mm, about 5 mm and about 6 mm, can be inserted into a narrow incision because it is constructed of a more pliable and soft material and can be folded, squeezed or rolled, more than it could be with the attached haptic, to be inserted into a considerably smaller incision using forceps or an injector. Because of this, and because the overall mass of the separate parts is less than the total mass, a multi-part IOL allows for insertion into a much narrower incision, than an assembled lens.
The lens can be implanted into the eye using a variety of surgical implant techniques known in the art. Although the preferred embodiment is that the lens be implanted into the anterior chamber, it can be envisioned that the lens could also be implanted in the posterior chamber or the lens could be comprised of two or more optics.
Additionally, any combination of the materials used will result in a lens that can be sterilized by a variety of standard methods such as ethylene oxide (ETO) or steam autoclaving at 250° F. or any other acceptable method.
Although the haptic of the preferred embodiment is described as being machine formed, it can also be envisioned that the haptic is molded or laser cut.
While this invention has been described with respect to various specific examples and embodiments, it is to be understood that the invention is not limited thereto and that it can be variously practiced within the scope of the following claims:
This is a Continuation of U.S. patent application Ser. No.10/056,971, filed Jan. 25, 2002, which claims priority to U.S. Provisional applications 60/269,045, filed Feb. 15, 2001 and 60/266,394, filed Feb. 1, 2001, each of which is herein incorporated by reference in its entirety.
Number | Date | Country | |
---|---|---|---|
60269045 | Feb 2001 | US | |
60266394 | Feb 2001 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10056971 | Jan 2002 | US |
Child | 11177776 | Jul 2005 | US |